These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27911604)

  • 1. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.
    Chalmers JD; Moffitt KL; Suarez-Cuartin G; Sibila O; Finch S; Furrie E; Dicker A; Wrobel K; Elborn JS; Walker B; Martin SL; Marshall SE; Huang JT; Fardon TC
    Am J Respir Crit Care Med; 2017 May; 195(10):1384-1393. PubMed ID: 27911604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Shoemark A; Cant E; Carreto L; Smith A; Oriano M; Keir HR; Perea L; Canto E; Terranova L; Vidal S; Moffitt K; Aliberti S; Sibila O; Chalmers JD
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31151955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Wagner BD; Luckey HK; Mann SA; Sagel SD; Regelmann W; Accurso FJ
    Chest; 2009 Dec; 136(6):1561-1568. PubMed ID: 19567495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.
    Stockley R; De Soyza A; Gunawardena K; Perrett J; Forsman-Semb K; Entwistle N; Snell N
    Respir Med; 2013 Apr; 107(4):524-33. PubMed ID: 23433769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil elastase in bronchiectasis.
    Gramegna A; Amati F; Terranova L; Sotgiu G; Tarsia P; Miglietta D; Calderazzo MA; Aliberti S; Blasi F
    Respir Res; 2017 Dec; 18(1):211. PubMed ID: 29258516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.
    Oriano M; Terranova L; Sotgiu G; Saderi L; Bellofiore A; Retucci M; Marotta C; Gramegna A; Miglietta D; Carnini C; Marchisio P; Chalmers JD; Aliberti S; Blasi F
    Pulm Pharmacol Ther; 2019 Dec; 59():101856. PubMed ID: 31626976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
    Chalmers JD; Haworth CS; Metersky ML; Loebinger MR; Blasi F; Sibila O; O'Donnell AE; Sullivan EJ; Mange KC; Fernandez C; Zou J; Daley CL;
    N Engl J Med; 2020 Nov; 383(22):2127-2137. PubMed ID: 32897034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study.
    Gao Y; Richardson H; Dicker AJ; Barton A; Kuzmanova E; Shteinberg M; Perea L; Goeminne PC; Cant E; Hennayake C; Pollock J; Abo Leyah H; Choi H; Polverino E; Blasi F; Welte T; Aliberti S; Long M; Shoemark A; Sibila O; Huang JTJ; Chalmers JD
    Am J Respir Crit Care Med; 2024 Jul; 210(1):77-86. PubMed ID: 38717347
    [No Abstract]   [Full Text] [Related]  

  • 9. Sputum neutrophil elastase and its relation to pediatric bronchiectasis severity: A cross-sectional study.
    Ali HA; Fouda EM; Salem MA; Abdelwahad MA; Radwan HH
    Health Sci Rep; 2022 May; 5(3):e581. PubMed ID: 35509417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.
    Sagel SD; Wagner BD; Anthony MM; Emmett P; Zemanick ET
    Am J Respir Crit Care Med; 2012 Nov; 186(9):857-65. PubMed ID: 22904182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway Inflammation in Children with Primary Ciliary Dyskinesia.
    Sagel SD; Kupfer O; Wagner BD; Davis SD; Dell SD; Ferkol TW; Hoppe JE; Rosenfeld M; Sullivan KM; Tiddens HAWM; Knowles MR; Leigh MW
    Ann Am Thorac Soc; 2023 Jan; 20(1):67-74. PubMed ID: 35984413
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.
    Sibila O; Perea L; Cantó E; Shoemark A; Cassidy D; Smith AH; Suarez-Cuartin G; Rodrigo-Troyano A; Keir HR; Oriano M; Ong S; Vidal S; Blasi F; Aliberti S; Chalmers JD
    Thorax; 2019 Sep; 74(9):835-842. PubMed ID: 31278172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.
    Keir HR; Shoemark A; Dicker AJ; Perea L; Pollock J; Giam YH; Suarez-Cuartin G; Crichton ML; Lonergan M; Oriano M; Cant E; Einarsson GG; Furrie E; Elborn JS; Fong CJ; Finch S; Rogers GB; Blasi F; Sibila O; Aliberti S; Simpson JL; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):873-884. PubMed ID: 33609487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications.
    Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Gu YY; Liu GH; Li HM; Chen RC; Zhong NS
    Respirology; 2015 Oct; 20(7):1073-81. PubMed ID: 26122009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients.
    Terranova L; Risé P; Gramegna A; Pinna C; Agostoni C; Syrén ML; Turolo S; Marchisio P; Amati F; Aliberti S; Sala A; Blasi F
    Respir Res; 2022 Dec; 23(1):363. PubMed ID: 36539829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Aliberti S; Ringshausen FC; Dhar R; Haworth CS; Loebinger MR; Dimakou K; Crichton ML; De Soyza A; Vendrell M; Burgel PR; McDonnell M; Skrgat S; Maiz Carro L; de Roux A; Sibila O; Bossios A; van der Eerden M; Kauppi P; Wilson R; Milenkovic B; Menendez R; Murris M; Borekci S; Munteanu O; Obradovic D; Nowinski A; Amorim A; Torres A; Lorent N; Van Braeckel E; Altenburg J; Shoemark A; Shteinberg M; Boersma W; Goeminne PC; Elborn JS; Hill AT; Welte T; Blasi F; Polverino E; Chalmers JD;
    Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 38609095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
    Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
    Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.
    Tsikrika S; Dimakou K; Papaioannou AI; Hillas G; Thanos L; Kostikas K; Loukides S; Papiris S; Koulouris N; Bakakos P
    Cytokine; 2017 Nov; 99():281-286. PubMed ID: 28863927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.